참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 1-Isopropyl-3-methyl-1H-pyrazol-5-amine | HCID 121018 | — |
| 반응물 | 2-[(2,5-dichloro-4-pyridinyl)amino]-N-(methyloxy)benzamide | HCID 57516896 | — |
| 시약 | Sodium t-butoxide | HCID 23676156 | — |
| 촉매 | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| 촉매 | (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladium | HCID 6505921 | — |
| 용매 | 1,4-Dioxane | HCID 31275 | — |
| 생성물 | Gsk-2256098 | HCID 46214930 | 92.72% |
반응 단계
dioxane (4.3 mL) was added to 2-(2,5-dichloropyridin-4-ylamino)-N-methoxybenzamide (142 mg, 0.45 mmol), 1-isopropyl-3-methyl-1H-pyrazol-5-amine (127 mg, 0.91 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (52.6 mg, 0.09 mmol), BIS(DIBENZYLIDENEACETONE)PALLADIUM (39.2 mg, 0.07 mmol) and sodium 2-methylpropan-2-olate (65.6 mg, 0.68 mmol) and sealed into a microwave tube. The reaction was heated to 150 °C for 30 minutes in the microwave reactor and cooled to RT. Reaction mixture from EN04231/5 was combined and filtered through a PTFE cup to remove insoluble precipitate, washed filter with dioxane and combined filtrates were purified by ion exchange chromatography, using an 25g SCX-2 column. The desired product was eluted from the column using 7M NH3/MeOH and product fractions were evaporated to dryness to afford crude product (457 mg). The crude product was purified by flash silica (40g grace) chromatography, elution gradient 0 to 5% MeOH in DCM. Pure fractions were evaporated to dryness to afford 2-(5-chloro-2-(1-isopropyl-3-methyl-1H-pyrazol-5-ylamino)pyridin-4-ylamino)-N-methoxybenzamide (175 mg, 93 %) as a beige solid.
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-7e62540b4ca7416d88222da262e8e74a |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|